Overview

Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
Clinical study for the developed voriconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.
Phase:
Phase 2
Details
Lead Sponsor:
Sara Botros
Treatments:
Voriconazole